BELLICUM PHARMACEUTICALS INC (BLCM) Forecast, Price Target & Analyst Ratings

NASDAQ:BLCM • US0794814048

Current stock price

0.622 USD
-0.07 (-9.72%)
At close:
0.6288 USD
+0.01 (+1.09%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BELLICUM PHARMACEUTICALS INC (BLCM).

Forecast Snapshot

Consensus Price Target

Price Target
$5.10
+ 719.94% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 9, 2023
Period
Q2 / 2023
EPS Estimate
-$0.30
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.10
Upside
+ 719.94%
From current price of $0.62 to mean target of $5.10, Based on 6 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for BLCM. The average price target is 5.1 USD. This implies a price increase of 719.94% is expected in the next year compared to the current price of 0.622.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BLCM Current Analyst RatingBLCM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

BLCM Historical Analyst RatingsBLCM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
BLCM was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BLCM.
In the previous month the buy percentage consensus was at a similar level.
BLCM was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-02-16Ladenburg ThalmannInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 9, 2023
Period
Q2 / 2023
EPS Estimate
-$0.30
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-127.54%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-222.22%
EPS (3 Months)
-45.00%

Next Earnings Summary

BLCM is expected to report earnings on 8/9/2023. The consensus EPS estimate for the next earnings is -0.3 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
BLCM revenue by date.BLCM revenue by date.
500K
-93.00%		6.2M
1,140.00%		1.5M
-75.81%
-100.00%		200.41M
EBITDA
YoY % growth
BLCM ebitda by date.BLCM ebitda by date.
-52.61M
32.62%		-24.283M
53.84%		-26.97M
-11.07%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
BLCM ebit by date.BLCM ebit by date.
-54.08M
36.57%		-24.388M
54.90%		-26.981M
-10.63%		-16.068M
40.45%		-14.462M
10.00%		-13.015M
10.00%		-11.714M
10.00%		-7.862M
32.88%
Operating Margin
BLCM operating margin by date.BLCM operating margin by date.
-10,816.00%-393.35%-1,798.73%N/AN/AN/AN/A-3.92%
EPS
YoY % growth
BLCM eps by date.BLCM eps by date.
-7.40
69.06%		-1.12
84.86%		-0.81
27.59%		-0.50
38.37%		-0.32
36.73%		-0.22
29.03%		-0.17
22.73%		-0.09
47.06%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.30
-127.54%		-0.09
60.09%		-0.04
79.70%
Revenue
Q2Q % growth
-100.00%
-100.00%
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-4.414M
32.48%		-2.206M
69.21%		-1.104M
84.96%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BLCM Yearly Revenue VS EstimatesBLCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2027 50M 100M 150M 200M
BLCM Yearly EPS VS EstimatesBLCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
19.89%
EPS Next 5 Year
13.54%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
187.52%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BELLICUM PHARMACEUTICALS INC / BLCM Forecast FAQ

What do analysts expect the price target to be for BELLICUM PHARMACEUTICALS INC (BLCM)?

6 analysts have analysed BLCM and the average price target is 5.1 USD. This implies a price increase of 719.94% is expected in the next year compared to the current price of 0.622.

What is the next earnings date for BLCM stock?

BELLICUM PHARMACEUTICALS INC (BLCM) will report earnings on 2023-08-09.

What are the consensus estimates for BLCM stock next earnings?

The consensus EPS estimate for the next earnings of BELLICUM PHARMACEUTICALS INC (BLCM) is -0.3 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for BLCM stock?

The number of analysts covering BELLICUM PHARMACEUTICALS INC (BLCM) is 6.